Publications

5674 Results

Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance)

Authors
M Fuchs;K Sato;D Niedzwiecki;X Ye;LB Saltz;RJ Meyer;RB Mowat;R Whittom;A Hantel;A Benson;D Atienza;M Messino;H Kindler;A Venook;S Ogino;K Wu;WC Willett;EL Giovannucci;JA Meyerhardt
Journal / Conference
PLOS ONE 9(6):e99816;
Year
2014
Research Committee(s)
Gastrointestinal
PMID
PMID24512953
PMC
PMC4019685
Study Number(s)
C89803

Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH

Authors
JG Cairncross;RB Jenkins;EG Shaw;C Giannini;DG Brachman;JC Buckner;KL Fink;L Souhami;NJ Laperriere;JT Huse;MP Mehta;WJ Curran
Journal / Conference
Journal of Clinical Oncology 32(8):783-790
Year
2014
Research Committee(s)
Brain
PMID
PMID24516018
PMC
PMC3940537

Functional partitioning of prostate cancer heritability in Europeans and African Americans from AAPC and BPC3 consortia reveals cell-type specificity

Authors
A Gusev;SS Strom;RA Kittles;BA Rybicki;JL Stanford;P Goodman;S Berndt;LB Signorello;J Carpten;G Casey;L Chu;DV Conti;KA Rand;Y Han;V Stephens;JM Ansell Hennis;EM John;EA Klein;S Kolb;L LeMarchand;SC Leske;AB Murphy;C Neslund-Dudas;C Pettaway;SM Gapstur;SL Zheng;S-Y Wu;JS Witte;J Xu;W Isaacs;SA Ingles;FR Schumacher;S Chanock;B Nemesure;WJ Blot;DO Stram;BE Henderson;AL Price;M Freedman;CA Haiman;B Pasaniuc
Journal / Conference
American Society of Human Genetics Annual Meeting (October 18-22, 2014, San Diego, CA), platform (oral) presentation;
Year
2014
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Impact of intrinsic subtype by PAM50 and other gene signatures on pathologic complete response (pCR) rates with neoadjuvant chemotherapy (NACT) +/- carboplatin (Cb) or bevacizumab (Bev) in triple-negative breast cancer (TNBC):correlative studies from CALGB 40603/CALGB 150709 (Alliance).

Authors
W Sikov;W Barry;A Hoadley;BN Pitcher;B Singh;S Tolaney;C Kuzma;T Pluard;G Somlo;E Port;M Golshan;DA Berry;O Hahn;L Carey;C Perou;C Hudis;E Winer
Journal / Conference
San Antonio Breast Cancer Symposium Annual Meeting (December 9-13, 2014, San Antonio, TX), abstr. [S4-05], oral presentation;
Year
2014
Research Committee(s)
Breast
Study Number(s)
CTSU/C40603

Adjuvant exemestane with ovarian suppression in pre-menopausal breast cancer

Authors
O Pagani;MM Regan;B Walley;G Fleming;M Colleoni;I Lang;H Gomez;C Tondini;H Burstein;EA Perez;E Ciruelos;V Stearns;H Bonnefoi;S Martino;M Rabaglio;AS Coates;RD Gelber;A Goldhirsch;P Francis
Journal / Conference
New England Journal of Medicine 371(2):107-118;
Year
2014
Research Committee(s)
Breast and Cancer Survivorship
PMID
PMID24881463
PMC
PMC4175521

Mutational analysis of CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer

Authors
KA Hoadley;WT Barry;B Pitcher;J Parker;M Wilkerson;N Henry;I Krop;DA Berry;ER Mardis;CM Perou;E Winer;CA Hudis;LA Carey
Journal / Conference
San Antonio Breast Cancer Symposium Annual Meeting (December 9-13, 2014, San Antonio, TX), abst. [S3-06], oral;
Year
2014
Research Committee(s)
Breast

Fulvestrant alone versus fulvestrant and everolimus versus fulvestrant, everolimus and anastrozole: A Phase III randomized, placebo-controlled trial in postmenopausal patients with hormone-receptor-positive stage IV breast cancer: SWOG-Clinical Trials Initiative (CTI)* S1222

Authors
G Somlo;W Barlow;HCF Moore;J Gralow;A Schott;DF Hayes;P Kuhn;JB Hicks;DL Lew;D Tripathy;G Hortobagyi
Journal / Conference
San Antonio Breast Cancer Symposium Annual Meeting (December 9-13, 2014, San Antonio, TX), abstr. [OT2-1-01], poster;
Year
2014
Research Committee(s)
Breast
Study Number(s)
S1222

Historical controls for metastatic pancreatic cancer: benchmarks for planning and analyzing single arm phase II trials

Authors
PA Philip;K Chansky;L Rubenstein;M Leblanc;L Seymour;SP Ivy;SR Alberts;PJ Catalano;J Crowley
Journal / Conference
Clinical Cancer Research 20(16):4176-4185;
Year
2014
Research Committee(s)
Gastrointestinal
PMID
PMID24914040
PMC
PMC4296727
Study Number(s)
S0107, S0205, SWOG-8916, SWOG-8933, SWOG-9100, SWOG-9135, SWOG-9413, S9629, S9924

Recurrence score and clinicopathologic characteristics of TAILORx participants by race and ethnicity

Authors
JA Sparano;RJ Gray;TJ Whelan;K Albain;D Hayes;C Geyer;EC Dees;EA Perez;JA Olson;MM Keane;C Sologuren;R Reddi;TF Goggins;IA Mayer;AM Brufsky;DL Toppmeyer;V Kaklamani;JN Atkins;J Berenberg;GW Sledge
Journal / Conference
Journal of Clinical Oncology Vol 32, No 26_suppl, 2014: 36; ASCO Breast Cancer Symposium (September 4-6, 2014, San Francisco, CA);
Year
2014
Research Committee(s)
Breast

Capecitabine and oxaliplatin in the preoperative multi-modality treatment of rectal cancer: surgical end points from national surgical adjuvant breast and bowel project trial R-04

Authors
MJ O'Connell;LH Colangelo;RW Beart;NJ Petrilli;CJ Allegra;S Sharif;HC Pitot;AF Shields;JC Landry;DP Ryan;DS Parda;M Mohiuddin;A Arora;L Evans;N Bahary;G Soori;J Eakle;JM Robertson;DF Moore;M Mullane;BT Marchello;PJ Ward;TF Wozniak;MS Roh;G Yothers;N Wolmark
Journal / Conference
Journal of Clinical Oncology 32(18):1927-1934
Year
2014
Research Committee(s)
Gastrointestinal
PMID
PMID24799484
PMC
PMC4050205